None listed
Conditions
Brief summary
Through a co-design study we have designed an online Prescription Opioid Safety Toolkit to increase consumers knowledge about opioid pain medicines and safety relating to their use. This study will test if the effect of the Toolkit on opioid safety knowledge and behaviours, and the acceptability of the Toolkit prior to a planned national dissemination campaign.
Interventions
The intervention condition is exposure to the online Prescription Opioid Safety Toolkit that has been co-designed for this trial. The Prescription Opioid Safety Toolkit will include interactive self-completed opioid outcome tools, videos and other information designed for consumers on safer opioid use, including information on naloxone. Participants randomised to the intervention arm will be emailed a link to the Toolkit and asked to engage with the online resource initially for 30-60 minutes before completing a brief (10 min) follow up survey at Time 1, and a further 20-min follow up survey 4 weeks later at Time 2. Participants will be advised that they may choose to spend longer on the website initially and can or return to the online materials at a later time. To monitor adherence, participants will be asked at Time 1 how long they initially spent viewing the online material, as well as confirming that the Toolkit has been accessed via the link provided and which elements of the Toolkit are accessed and/or completed.
Sponsors
Study design
Eligibility
Inclusion criteria
Eligible participants will be Australian adults aged at least 18 who have been prescribed opioids for non-cancer pain for at least two weeks, and have taken opioids in the past four weeks.
Exclusion criteria
Unable to provide voluntary informed consent